Trials / Completed
CompletedNCT00824434
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compile acute (30-day) clinical outcomes data and 9-month angiographic and intravascular ultrasound (IVUS) data for the PROMUS Element™ Everolimus- Eluting Coronary Stent System in the treatment of patients with a single de novo atherosclerotic lesion
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PROMUS Element™ | Drug eluting coronary stent system |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-09-01
- Completion
- 2010-08-01
- First posted
- 2009-01-16
- Last updated
- 2012-08-30
- Results posted
- 2012-03-07
Locations
17 sites across 4 countries: Australia, Malaysia, New Zealand, Singapore
Source: ClinicalTrials.gov record NCT00824434. Inclusion in this directory is not an endorsement.